What were the inclusion criteria for the Flather Nebivolol study?
The inclusion criteria for the Flather Nebivolol study was a clinical history of chronic heart failure with at least one of the following features: documented hospital admission within the previous 12 months with a discharge diagnosis of congestive heart failure or documented LVEF 35% within the previous 6 months failure in the 6 weeks prior to randomization a change in cardiovascular drug therapy in the 2 weeks prior to randomization heart failure due primarily to uncorrected valvular heart disease.